[1]
Gangopadhyay, K.K., Sharma, A., Kumar, A., Mehta, A., Mohan, J.C., Malige, M., Kumar, R.B., Mittal, R., Singh, S.K., Singh, S.K., Shaikh, S.S., Malhotra, V. and Sowmiya, M.K. 2025. Consensus of expert through Indian perspective on the fixed-dose combination dapagliflozin and linagliptin combination in type 2 diabetes mellitus: CONSEPDT study. International Journal of Research in Medical Sciences. 14, 1 (Dec. 2025), 333–340. DOI:https://doi.org/10.18203/2320-6012.ijrms20254400.